Form 483

BAXALTA US INC. Form 483, 2022-09-15

FDA issued a Form 483 to BAXALTA US INC. on 2022-09-15 with 3 public-safe observations.

483· Form 483 issuedBiologics3 observations

BAXALTA US INC. · Round Lake, United States · Issued September 15, 2022

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Sep 2022
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Claire M Minden

15 Sep 2022
21 CFR 211.84(d)(3)

Establish reliability of supplier's C of A

Cited by Claire M Minden

15 Sep 2022
21 CFR 211.84(d)(6)

Microbiological Contamination Exam

Cited by Claire M Minden

Inspected site

BUBAXALTA US INC.Round Lake, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(6)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 3 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere